VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,511,000 | -55.8% | 136,975 | -41.8% | 0.24% | -33.1% |
| Q4 2016 | $3,420,000 | +112.8% | 235,528 | +259.9% | 0.37% | +76.8% |
| Q3 2016 | $1,607,000 | -18.9% | 65,441 | -33.5% | 0.21% | -10.8% |
| Q2 2016 | $1,982,000 | +17.1% | 98,428 | +53.0% | 0.23% | -63.2% |
| Q1 2016 | $1,692,000 | +632.5% | 64,324 | +2736.2% | 0.63% | +473.6% |
| Q4 2015 | $231,000 | -91.3% | 2,268 | -84.8% | 0.11% | -84.9% |
| Q3 2015 | $2,660,000 | -20.7% | 14,910 | -11.7% | 0.73% | -39.5% |
| Q1 2015 | $3,354,000 | +1431.5% | 16,884 | +1002.1% | 1.20% | +947.8% |
| Q4 2014 | $219,000 | -66.8% | 1,532 | -69.4% | 0.12% | -46.3% |
| Q1 2014 | $660,000 | – | 5,008 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |